Examination Report |
1 | Authorization Document (POA) | 09 Jan 2017 |
1 | TM-1 | 09 Jan 2017 |
2 | Additional Representation Sheet | 09 Jan 2017 |
3 | Authorization Document (POA) | 09 Jan 2017 |
3 | TM-1 | 09 Jan 2017 |
4 | Reply to Exam Report (MIS-R) | 15 Mar 2017 |
5 | Authorization Letter | 15 Jan 2019 |
6 | Journal Copy | 26 Apr 2019 |
7 | TM-O(NOTICE OF OPPOSITION) | 02 May 2019 |
1 | Hearing Notice (Show Cause) | 7416286 | 3616832 | 05 Dec 2018 |
2 | Tribunal Accepted Notice for : 3452927 | 7637184 | 3691266 | 17 Jan 2019 |
3 | Opposition Notice | 8439499 | 4157718 | 17 Jun 2019 |
4 | Order Form of 21(2) | 9570422 | 4708260 | 13 Jan 2020 |
The application for Tyolol was made on 09 January 2017.
The trademark applicant for Tyolol is BLISS GVS PHARMA.
Tyolol is applied in class(es) 5.
Application for Tyolol is on Abandoned stage.
Application Id allotted to Tyolol is 3452927.
Trademark agent or attorney for the application is H. P. Associates.
Tyolol filed with the Intellectual property office as a DEVICE.